Results 121 to 130 of about 7,310 (259)

THE MOST FREQUENT TYPES OF DEMYELINATIVE CHARCOT-MARIE-TOOTH DISEASE IN SLOVENIA: A POPULATION-BASED STUDY

open access: yesZdravniški Vestnik, 2003
Background. The most common genetic defect in demyelinative type of Charcot-Marie-Tooth disease (CMT1) is dominantly inherited duplication of 17p11.2 (CMT1A).
Lea Leonardis   +2 more
doaj  

Mechanical sensitization of sensory afferents after passive transfer of fibromyalgia IgG

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend In addition to widespread pain and fatigue, people with fibromyalgia (FM) experience sensory abnormalities and report lingering, painful sensations after touch or mechanical probing of the skin. Administration of IgG purified from FM patients to mice transfers symptoms and signs of FM.
Mathilde R. Israel   +5 more
wiley   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, Volume 30, Issue 6, Page 801-809, December 2026.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Transient Atrioventricular Block Secondary to Coronary Artery Embolism From Infective Endocarditis Following CAR T‐Cell Therapy

open access: yesJournal of Arrhythmia, Volume 42, Issue 6, December 2026.
Silent infective endocarditis after CAR‐T therapy caused septic embolic occlusion of a septal coronary branch, producing localized myocardial infarction involving the His bundle region and transient complete atrioventricular block. This case highlights a rare, pathologically confirmed mechanism of conduction disturbance.
Kento Kito   +8 more
wiley   +1 more source

Efficacy and Safety of Crisugabalin for Inadequately Controlled Diabetic Peripheral Neuropathic Pain: A Randomized, Active‐Controlled, Phase 2 Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11946-11954, December 2026.
ABSTRACT Aims Crisugabalin (HSK16149), a selective γ‐aminobutyric acid (GABA) analog, has shown preliminary efficacy in controlling diabetic peripheral neuropathic pain (DPNP), but efficacy in patients with inadequate response to prior pregabalin treatment remains unknown. Materials and Methods This multicentre randomized controlled trial was conducted
Yaming Li   +11 more
wiley   +1 more source

Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double‐Blinded, Placebo‐Controlled Crossover Study

open access: yesJournal of the Peripheral Nervous System, Volume 31, Issue 4, December 2026.
ABSTRACT Background and Aims Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an immune‐mediated neuropathy that may cause persistent disability despite immunoglobulin treatment. Ion channel dysfunction has been demonstrated in CIDP, but no therapies specifically target this mechanism.
Peter Nørregaard Hansen   +5 more
wiley   +1 more source

Intermittent Maple Syrup Urine Disease Presenting With Chronic Demyelinating Polyneuropathy: A Genetically Confirmed DBT‐Related Case

open access: yesJournal of the Peripheral Nervous System, Volume 31, Issue 4, December 2026.
ABSTRACT Background and Aims Maple syrup urine disease (MSUD) is an inherited disorder of branched‐chain amino acid metabolism caused by deficiency of the branched‐chain α‐keto acid dehydrogenase complex. Neurological manifestations predominantly involve the central nervous system, whereas peripheral nervous system involvement has been rarely reported.
Gustavo Rodrigues Ferreira Gomes   +7 more
wiley   +1 more source

Bispecific antibodies targeting B‐cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions

open access: yesCancer, Volume 132, Issue 22, 15 November 2026.
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato   +5 more
wiley   +1 more source

Alterações audiológicas na doença de Charcot-Marie-Tooth Audiological findings in the Charcot-Marie-Tooth disease

open access: yesBrazilian Journal of Otorhinolaryngology, 2011
Erika Fukushima   +2 more
doaj   +1 more source

Lumps, Bumps, and Diagnostic Stumps: A Case Report of IgG4‐Related Disease

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT IgG4‐related disease and idiopathic multicentric Castleman disease are rare conditions that can present with overlapping features, complicating diagnosis and delaying proper treatment.
Michael Miller   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy